Our study is limited by a relatively small sample size, especially those with NT-proBNP level ≥400 pg/dL due to our exclusion of heart failure, in our cohort of women with signs and symptoms of ischemia, preserved LVEF and no obstructive CAD. The gene discussed is NPPB; the disease is heart failure.